BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 24141039)

  • 1. Chronic cholestatic liver diseases: clues from histopathology for pathogenesis.
    Pollheimer MJ; Fickert P; Stieger B
    Mol Aspects Med; 2014 Jun; 37():35-56. PubMed ID: 24141039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis.
    Adams DH; Hubscher SG; Shaw J; Johnson GD; Babbs C; Rothlein R; Neuberger JM
    Hepatology; 1991 Sep; 14(3):426-31. PubMed ID: 1714872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis.
    Sakisaka S; Kawaguchi T; Taniguchi E; Hanada S; Sasatomi K; Koga H; Harada M; Kimura R; Sata M; Sawada N; Mori M; Todo S; Kurohiji T
    Hepatology; 2001 Jun; 33(6):1460-8. PubMed ID: 11391535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology and Diseases of the Proximal Pathways of the Biliary System.
    Nakanishi Y; Saxena R
    Arch Pathol Lab Med; 2015 Jul; 139(7):858-66. PubMed ID: 26125426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on the management of cholestatic liver diseases.
    Appanna G; Kallis Y
    Clin Med (Lond); 2020 Sep; 20(5):513-516. PubMed ID: 32934048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognizing primary biliary cirrhosis and primary sclerosing cholangitis.
    Buckley SE; DiPalma JA
    Am Fam Physician; 1996 Jan; 53(1):195-200. PubMed ID: 8546046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models of cholestasis: An update on inflammatory cholangiopathies.
    Mariotti V; Cadamuro M; Spirli C; Fiorotto R; Strazzabosco M; Fabris L
    Biochim Biophys Acta Mol Basis Dis; 2019 May; 1865(5):954-964. PubMed ID: 30398152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced Bile Duct Injury - A Short Review.
    Dobreva I; Karagyozov P
    Curr Drug Metab; 2020; 21(4):256-259. PubMed ID: 32310045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathology of chronic cholestasis and adult ductopenic syndrome.
    Desmet VJ
    Clin Liver Dis; 1998 May; 2(2):249-64, viii. PubMed ID: 15560031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Importance of liver puncture biopsy and endoscopic retrograde cholangiography in patients with chronic anicteric unexplained cholestasis. A retrospective study in 79 patients].
    Sapey T; Turlin B; Canva-Delcambre V; Mendler MH; Deugnier Y; Brissot P; Guyader D
    Gastroenterol Clin Biol; 1999 Feb; 23(2):178-85. PubMed ID: 10353011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory disease of the bile ducts-cholangiopathies: liver biopsy challenge and clinicopathological correlation.
    Portmann B; Zen Y
    Histopathology; 2012 Jan; 60(2):236-48. PubMed ID: 21668470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic determinants of cholangiopathies: Molecular and systems genetics.
    Reichert MC; Hall RA; Krawczyk M; Lammert F
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1484-1490. PubMed ID: 28757171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases.
    Li Y; Tang R; Leung PSC; Gershwin ME; Ma X
    Autoimmun Rev; 2017 Sep; 16(9):885-896. PubMed ID: 28698093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic cholestatic liver diseases - Primary biliary cholangitis and Primary sclerosing cholangitis.
    Fejfar T; Vaňásek T; Hůlek P
    Vnitr Lek; 2020; 66(5):287-300. PubMed ID: 32942866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xenobiotic-induced liver injury and fibrosis.
    Österreicher CH; Trauner M
    Expert Opin Drug Metab Toxicol; 2012 May; 8(5):571-80. PubMed ID: 22452290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary sclerosing cholangitis.
    Rodriguez HJ; Bass NM
    Semin Gastrointest Dis; 2003 Oct; 14(4):189-98. PubMed ID: 14719769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary sclerosing cholangitis, a vanishing bile duct disease.
    van Berge Henegouwen GP
    Neth J Med; 1987 Aug; 31(1-2):27-35. PubMed ID: 3658059
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium.
    Strazzabosco M; Fiorotto R; Cadamuro M; Spirli C; Mariotti V; Kaffe E; Scirpo R; Fabris L
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1374-1379. PubMed ID: 28754453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathology of cholestasis.
    Li MK; Crawford JM
    Semin Liver Dis; 2004 Feb; 24(1):21-42. PubMed ID: 15085484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathology of cholestasis.
    Desmet VJ
    Verh Dtsch Ges Pathol; 1995; 79():233-40. PubMed ID: 8600686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.